Ovid Therapeutics Inc. (OVID)

NASDAQ: OVID · Delayed Price · USD
1.84
-0.05 (-2.65%)
At close: May 25, 2022 4:00 PM
1.90
0.06 (3.26%)
After-hours:May 25, 2022 4:38 PM EDT

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year2021202020192018201720162015
Revenue
208.3812.6200000
Revenue Growth (YoY)
1551.57%------
Gross Profit
208.3812.6200000
Selling, General & Admin
37.2330.6319.2519.1415.0412.956.58
Research & Development
46.9463.4242.1633.7949.979.596.61
Operating Expenses
84.1794.0561.4152.9365.0122.5413.19
Operating Income
124.21-81.43-61.41-52.93-65.01-22.54-13.19
Other Expense / Income
0.05-0.4-0.95-0.95-0.2-0.12-0.03
Pretax Income
124.16-81.04-60.46-51.98-64.81-22.41-13.16
Income Tax
1.33000000
Net Income
122.83-81.04-60.46-51.98-64.81-22.41-13.16
Net Income Common
122.83-81.04-60.46-51.98-64.81-22.41-13.16
Shares Outstanding (Basic)
67583925191010
Shares Outstanding (Diluted)
68583925191010
Shares Change
16.45%49.04%59.22%27.33%96.62%1.44%-
EPS (Basic)
1.78-1.39-1.54-2.11-3.35-2.28-1.36
EPS (Diluted)
1.76-1.39-1.54-2.11-3.35-2.28-1.36
Free Cash Flow Per Share
1.75-0.89-1.30-1.85-1.63-1.81-0.57
Gross Margin
100.00%100.00%-----
Operating Margin
59.61%-645.40%-----
Profit Margin
58.95%-642.26%-----
Free Cash Flow Margin
56.83%-409.85%-----
Effective Tax Rate
1.07%0.00%0.00%0.00%0.00%0.00%0.00%
EBITDA
124.4-80.73-60.21-51.84-64.73-22.36-13.15
EBITDA Margin
59.70%-639.83%-----
EBIT
124.16-81.04-60.46-51.98-64.81-22.41-13.16
EBIT Margin
59.58%-642.26%-----
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).